Annual Total Debt
$6.00 M
-$546.30 K-8.35%
30 September 2022
Summary:
NeuBase Therapeutics annual total debt is currently $6.00 million, with the most recent change of -$546.30 thousand (-8.35%) on 30 September 2022. During the last 3 years, it has fallen by -$546.30 thousand (-8.35%).NBSE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$5.34 M
-$139.10 K-2.54%
30 September 2023
Summary:
NeuBase Therapeutics quarterly total debt is currently $5.34 million, with the most recent change of -$139.10 thousand (-2.54%) on 30 September 2023.NBSE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -8.3% | -18.4% |
| 5 y5 years | +4778.7% | +4241.0% |
NBSE Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -8.4% | -18.5% |
NeuBase Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $5.34 M(-2.5%) |
| June 2023 | - | $5.47 M(-2.6%) |
| Mar 2023 | - | $5.62 M(-2.5%) |
| Dec 2022 | - | $5.76 M(-3.9%) |
| Sept 2022 | $6.00 M(-8.4%) | $6.00 M(-2.7%) |
| June 2022 | - | $6.16 M(-2.5%) |
| Mar 2022 | - | $6.32 M(+0.3%) |
| Dec 2021 | - | $6.30 M(-3.7%) |
| Sept 2021 | $6.54 M(+4620.2%) | $6.54 M(+1.1%) |
| June 2021 | - | $6.47 M(>+9900.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | - | $0.00(-100.0%) |
| Sept 2020 | $138.60 K(+12.8%) | $138.60 K(-56.7%) |
| June 2020 | - | $320.40 K(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | - | $49.50 K(-59.7%) |
| Sept 2019 | $122.90 K(-50.8%) | $122.90 K(>+9900.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Sept 2018 | $250.00 K(+135.0%) | $250.00 K(+37.7%) |
| June 2018 | - | $181.50 K(-37.0%) |
| Mar 2018 | - | $287.90 K(>+9900.0%) |
| Dec 2017 | - | $0.00(-100.0%) |
| Sept 2017 | $106.40 K(+21.2%) | $106.40 K(-32.9%) |
| June 2017 | - | $158.60 K(-39.3%) |
| Mar 2017 | - | $261.30 K(>+9900.0%) |
| Dec 2016 | - | $0.00(-100.0%) |
| Sept 2016 | $87.80 K(+82.5%) | $87.80 K(-33.0%) |
| June 2016 | - | $131.00 K(-39.3%) |
| Mar 2016 | - | $215.80 K(>+9900.0%) |
| Dec 2015 | - | $0.00(-100.0%) |
| Sept 2015 | $48.10 K(+9.6%) | $48.10 K(-59.6%) |
| June 2015 | - | $119.20 K(-37.0%) |
| Mar 2015 | - | $189.20 K(>+9900.0%) |
| Dec 2014 | - | $0.00(-100.0%) |
| Sept 2014 | $43.90 K(+211.3%) | $43.90 K(-59.7%) |
| June 2014 | - | $108.90 K(-43.9%) |
| Mar 2014 | - | $194.00 K(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | $14.10 K(-35.9%) | $14.10 K(-66.7%) |
| June 2013 | - | $42.40 K(+1077.8%) |
| Mar 2013 | - | $3600.00(-52.0%) |
| Dec 2012 | - | $7500.00(-65.9%) |
| Sept 2012 | $22.00 K(>+9900.0%) | $22.00 K(-50.5%) |
| June 2012 | - | $44.40 K(-8.1%) |
| Mar 2012 | - | $48.30 K(>+9900.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sept 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $1700.00(-75.0%) |
| Dec 2010 | - | $6800.00(-61.1%) |
| Sept 2010 | $17.50 K(-96.2%) | $17.50 K(-73.2%) |
| June 2010 | - | $65.30 K(-21.6%) |
| Mar 2010 | - | $83.30 K(-72.9%) |
| Dec 2009 | - | $307.00 K(-33.3%) |
| Sept 2009 | $460.00 K(>+9900.0%) | $460.00 K(-0.4%) |
| June 2009 | - | $462.00 K(-14.3%) |
| Mar 2009 | - | $539.00 K(>+9900.0%) |
| Dec 2008 | - | $0.00(0.0%) |
| Sept 2008 | $0.00(0.0%) | $0.00(0.0%) |
| June 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sept 2007 | $0.00(0.0%) | $0.00(0.0%) |
| June 2007 | - | $0.00(-100.0%) |
| Mar 2007 | - | $157.00 K(>+9900.0%) |
| Dec 2006 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(-100.0%) |
| Mar 2006 | - | $55.00 K(-7.9%) |
| Dec 2005 | $59.70 K(-23.7%) | $59.70 K(-7.4%) |
| Sept 2005 | - | $64.50 K(-6.5%) |
| June 2005 | - | $69.00 K(-6.8%) |
| Mar 2005 | - | $74.00 K(-5.4%) |
| Dec 2004 | $78.20 K(+28.0%) | $78.20 K(-5.0%) |
| Sept 2004 | - | $82.30 K(+48.3%) |
| June 2004 | - | $55.50 K(-4.1%) |
| Mar 2004 | - | $57.90 K |
| Dec 2003 | $61.10 K | - |
FAQ
- What is NeuBase Therapeutics annual total debt?
- What is the all time high annual total debt for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for NeuBase Therapeutics?
What is NeuBase Therapeutics annual total debt?
The current annual total debt of NBSE is $6.00 M
What is the all time high annual total debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual total debt is $6.54 M
What is NeuBase Therapeutics quarterly total debt?
The current quarterly total debt of NBSE is $5.34 M
What is the all time high quarterly total debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly total debt is $6.54 M